A branch of Health Canada, which oversees the regulation of pharmaceutical
and other health-related products in Canada, has published draft guidelines
on health product names. Under the proposed procedures, Health Canada will (i)
screen new drug names to ensure that they are not misleading or likely to be
confused with existing drug names, and (ii) attempt to reduce the risks created
by confusing product names that are already on the market.